Hua Zhu Ke - Concepedia

Author

Hua Zhu Ke

Amgen (United States)ORCID

Also Known As

H Z Ke, H. Ke, H. Z. Ke, H.Z Ke, H.Z. Ke, Hanchen Ke, Hua Ke, Hua Z Ke, Hua Z. Ke, Hua Zhu KE

161

Publications

11.7K

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Pfizer (United States)University of Utah UCB Pharma (United Kingdom)Guangdong Medical College

About

Hua Zhu Ke is an author at Amgen (United States) specializing in medicine, osteoporosis, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	61	5.4K
2	Health Sciences	18	21	1.2K
3	Natural Sciences	2	2	183
4	Engineering	1	1	16
5	Social Sciences	1	1	17

Hua Zhu Ke

110

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength Xiaodong Li, Michael S. Ominsky, Qing‐Tian Niu, Journal of Bone and Mineral Research	2008	932
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis Xiaodong Li, Michael S. Ominsky, Kelly Warmington, Journal of Bone and Mineral Research SclerostinImmunologyOrthopaedic SurgeryRat ModelOsteoporosis	2008	773
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia Ji Li, Ildiko Sarosi, Russell C. Cattley, Bone MechanobiologySclerostinDkk1-mediated InhibitionBone Morphogenic ProteinCell Signaling	2006	429
Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation Xiaofeng Li, Peng Liu, Wenzhong Liu, Nature Genetics Orthopaedic SurgeryMatrix FormationBone Morphogenic ProteinTerminal Osteoblast DifferentiationOsteoarthritis	2005	340
Targeted Disruption of the Osteoblast/Osteocyte Factor 45 Gene (OF45) Results in Increased Bone Formation and Bone Mass Lori C. Gowen, Donna N. Petersen, Amy L. Mansolf, Journal of Biological Chemistry	2003	296
Deletion of the P2X<sub>7</sub>Nucleotide Receptor Reveals Its Regulatory Roles in Bone Formation and Resorption Hua Zhu Ke, Hong Qi, A. Frederik Weidema, Molecular Endocrinology SclerostinMolecular BiologyBone FormationRegulatory RolesOrthopaedic Surgery	2003	289
Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family Vishwas Paralkar, Amy L. Vail, W A Grasser, Journal of Biological Chemistry	1998	288
The P2X7 Nucleotide Receptor Mediates Skeletal Mechanotransduction Jiliang Li, Dawei Liu, Hua Zhu Ke, Journal of Biological Chemistry	2005	266
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones Michael S. Ominsky, Chaoyang Li, Xiaodong Li, Journal of Bone and Mineral Research	2010	264
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair Mónica Florio, Kannan Gunasekaran, Marina Stolina, Nature Communications	2016	248

Page 1